Literature DB >> 21596315

Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry.

Xiaodong Huang1, Matthew K Summers, Victoria Pham, Jennie R Lill, Jinfeng Liu, Gwanghee Lee, Donald S Kirkpatrick, Peter K Jackson, Guowei Fang, Vishva M Dixit.   

Abstract

Cell cycle progression requires the E3 ubiquitin ligase anaphase-promoting complex (APC/C), which uses the substrate adaptors CDC20 and CDH1 to target proteins for proteasomal degradation. The APC(CDH1) substrate cyclin A is critical for the G1/S transition and, paradoxically, accumulates even when APC(CDH1) is active. We show that the deubiquitinase USP37 binds CDH1 and removes degradative polyubiquitin from cyclin A. USP37 was induced by E2F transcription factors in G1, peaked at G1/S, and was degraded in late mitosis. Phosphorylation of USP37 by CDK2 stimulated its full activity. USP37 overexpression caused premature cyclin A accumulation in G1 and accelerated S phase entry, whereas USP37 knockdown delayed these events. USP37 was inactive in mitosis because it was no longer phosphorylated by CDK2. Indeed, it switched from an antagonist to a substrate of APC(CDH1) and was modified with degradative K11-linked polyubiquitin.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596315     DOI: 10.1016/j.molcel.2011.03.027

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  82 in total

Review 1.  Insights into phosphorylation-dependent mechanisms regulating USP1 protein stability during the cell cycle.

Authors:  Xiomaris M Cotto-Rios; Mathew J K Jones; Tony T Huang
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

Review 2.  Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint.

Authors:  Key-Hwan Lim; Myoung-Hyun Song; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2016-01-13       Impact factor: 9.261

3.  Nonparametric Bayesian evaluation of differential protein quantification.

Authors:  Oliver Serang; A Ertugrul Cansizoglu; Lukas Käll; Hanno Steen; Judith A Steen
Journal:  J Proteome Res       Date:  2013-09-11       Impact factor: 4.466

4.  Ubiquitin-interacting motifs confer full catalytic activity, but not ubiquitin chain substrate specificity, to deubiquitinating enzyme USP37.

Authors:  Hidetaka Tanno; Takeshi Shigematsu; Shuhei Nishikawa; Akira Hayakawa; Kimitoshi Denda; Toshiaki Tanaka; Masayuki Komada
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

Review 5.  APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.

Authors:  Morgan S Schrock; Benjamin R Stromberg; Luke Scarberry; Matthew K Summers
Journal:  Semin Cancer Biol       Date:  2020-03-09       Impact factor: 15.707

Review 6.  Dissecting the mechanisms of cell division.

Authors:  Joseph Y Ong; Jorge Z Torres
Journal:  J Biol Chem       Date:  2019-06-07       Impact factor: 5.157

7.  FEM1 proteins are ancient regulators of SLBP degradation.

Authors:  John F Dankert; Julia K Pagan; Natalia G Starostina; Edward T Kipreos; Michele Pagano
Journal:  Cell Cycle       Date:  2017-01-24       Impact factor: 4.534

8.  USP37 promotes deubiquitination of HIF2α in kidney cancer.

Authors:  Kai Hong; Lianxin Hu; Xijuan Liu; Jeremy M Simon; Travis S Ptacek; Xingnan Zheng; Chengheng Liao; Albert S Baldwin; Qing Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-27       Impact factor: 11.205

9.  CYLD regulates spindle orientation by stabilizing astral microtubules and promoting dishevelled-NuMA-dynein/dynactin complex formation.

Authors:  Yunfan Yang; Min Liu; Dengwen Li; Jie Ran; Jinmin Gao; Shaojun Suo; Shao-Cong Sun; Jun Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

10.  HSP105 recruits protein phosphatase 2A to dephosphorylate β-catenin.

Authors:  Nancy Yu; Michael Kakunda; Victoria Pham; Jennie R Lill; Pan Du; Matthew Wongchenko; Yibing Yan; Ron Firestein; XiaoDong Huang
Journal:  Mol Cell Biol       Date:  2015-02-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.